Annual and Interim Reports
ANNUAL REPORT 2015
Presentations and Webcasts
WHO WE ARE
How We Operate
Our R&D Strategy
RESEARCH AND EDUCATIONAL GRANTS
Science & Innovation
Search & Apply
Diversity & Inclusion
Culture & Values
Learning and Development
US Internship Program
Work Life Balance
A significant focus on areas of high unmet medical need and rare disease patient populations.
Learn more about our committment in the fight against rare diseases in this infographic.
See how much you know about Chronic Dry Eye and learn about the importance of showing your eyes some love.
Learn more about a new campaign generating awareness and understanding of Chronic Dry Eye and symptoms.
See how much you know about VWD, the world’s most common inherited bleeding disorder.
Learn more about dry eye in this infographic.
Shire’s CEO, Flemming Ornskov, announces the close of the Shire-Baxalta combination.
Learn more about the leading global biotechnology company focused on serving patients with rare diseases & other highly specialized conditions.
By following this link you will be leaving a Shire controlled website for a third party website. Please note that Shire is not responsible or liable for any third party website and the website may not be appropriate for all audiences.